These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38756760)
1. Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update. Portillo V; Ragozzino S; Stavropoulou E; El-Khoury C; Bochud PY; Lamoth F; Khanna N; Neofytos D Open Forum Infect Dis; 2024 May; 11(5):ofae201. PubMed ID: 38756760 [TBL] [Abstract][Full Text] [Related]
2. Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation. Glampedakis E; Roth R; Masouridi-Levrat S; Chalandon Y; Mamez AC; Giannotti F; Van Delden C; Neofytos D J Fungi (Basel); 2021 Sep; 7(10):. PubMed ID: 34682233 [TBL] [Abstract][Full Text] [Related]
3. When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients? Roth RS; Masouridi-Levrat S; Giannotti F; Mamez AC; Morin S; van Delden C; Chalandon Y; Neofytos D Mycoses; 2022 Nov; 65(11):1061-1067. PubMed ID: 35815918 [TBL] [Abstract][Full Text] [Related]
4. Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections. Roth RS; Masouridi-Levrat S; Giannotti F; Mamez AC; Glambedakis E; Lamoth F; Bochud PY; Erard V; Emonet S; Van Delden C; Kaiser L; Chalandon Y; Neofytos D Mycoses; 2022 Feb; 65(2):199-210. PubMed ID: 34936143 [TBL] [Abstract][Full Text] [Related]
5. Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress? Roth RS; Masouridi-Levrat S; Chalandon Y; Mamez AC; Giannotti F; Riat A; Fischer A; Poncet A; Glampedakis E; Van Delden C; Kaiser L; Neofytos D Open Forum Infect Dis; 2022 Jan; 9(1):ofab596. PubMed ID: 34993259 [TBL] [Abstract][Full Text] [Related]
6. Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold Infection. Ross JA; Lee B; Ma H; Tegtmeier B; Nanayakkara D; Dickter J; Spielberger R; Smith E; Pullarkat V; Forman SJ; Taplitz R; Nakamura R; Al Malki M; Dadwal SS Open Forum Infect Dis; 2024 Aug; 11(8):ofae409. PubMed ID: 39135965 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation. Herity LB; Cruz OA; Aziz MT J Oncol Pharm Pract; 2022 Jun; 28(4):794-804. PubMed ID: 33906508 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience. Neofytos D; Treadway S; Ostrander D; Alonso CD; Dierberg KL; Nussenblatt V; Durand CM; Thompson CB; Marr KA Transpl Infect Dis; 2013 Jun; 15(3):233-42. PubMed ID: 23432974 [TBL] [Abstract][Full Text] [Related]